학술논문

Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: A prospective, randomized controlled phase III trial
Document Type
Article
Source
In: Clinical Lymphoma, Myeloma and Leukemia. (Clinical Lymphoma, Myeloma and Leukemia, April 2013, 13(2):99-105)
Subject
Language
English
ISSN
21522650
21522669